Cargando…
Process Engineering of Biopharmaceutical Production in Moss Bioreactors via Model-Based Description and Evaluation of Phytohormone Impact
The moss Physcomitrella is an interesting production host for recombinant biopharmaceuticals. Here we produced MFHR1, a synthetic complement regulator which has been proposed for the treatment of diseases associated to the complement system as part of human innate immunity. We studied the impact of...
Autores principales: | Ruiz-Molina, Natalia, Parsons, Juliana, Schroeder, Sina, Posten, Clemens, Reski, Ralf, Decker, Eva L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891706/ https://www.ncbi.nlm.nih.gov/pubmed/35252145 http://dx.doi.org/10.3389/fbioe.2022.837965 |
Ejemplares similares
-
Glyco-engineering for biopharmaceutical production in moss bioreactors
por: Decker, Eva L., et al.
Publicado: (2014) -
Moss‐made pharmaceuticals: from bench to bedside
por: Reski, Ralf, et al.
Publicado: (2015) -
Unexpected Arabinosylation after Humanization of Plant Protein N-Glycosylation
por: Bohlender, Lennard L., et al.
Publicado: (2022) -
Cyberbiosecurity for Biopharmaceutical Products
por: Mantle, Jennifer L., et al.
Publicado: (2019) -
Recombinant Production of MFHR1, A Novel Synthetic Multitarget Complement Inhibitor, in Moss Bioreactors
por: Top, Oguz, et al.
Publicado: (2019)